Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
Zachariae H, Abrams B, Bleehen SS, Bräutigam M, Burrows D, Ettelt MJ, Fry L, Happle R, Haustein UF, Ganslandt J, Jung EG, Knop J, Kühne KH, Mellein B, Mørk NJ, Rogers S, Schmidt AG, Schopf RE, Sumner M, Taube KM, Weidinger G, Wurdel C, Zahn E.
Zachariae H, et al. Among authors: schopf re.
Dermatology. 1998;196(2):231-6. doi: 10.1159/000017880.
Dermatology. 1998.
PMID: 9568413
Clinical Trial.